Average Co-Inventor Count = 6.32
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Pharma Aktiengesellschaft (17 from 379 patents)
2. Bayer Intellectual Property Gmbh (12 from 721 patents)
3. Bayer Aktiengesellschaft (3 from 12,170 patents)
4. The Broad Institute, Inc. (2 from 450 patents)
5. Bayer Pharma Aktiengesellscaft (1 from 1 patent)
30 patents:
1. 11701347 - Use of 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{4-[(S-methylsulfonimidoyl)methyl]pyridin-2-yl}pyridin-2-amine for treating diffuse large B-cell lymphoma
2. 11492358 - Macrocyclic indole derivatives
3. 10981932 - Macrocyclic indole derivatives
4. 10717749 - Macrocyclic sulfondiimine compounds
5. 10214542 - Modified macrocyclic compounds
6. 10124007 - Combination of PI3K-inhibitors
7. 9962389 - 4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
8. 9963464 - Macrocyclic compounds
9. 9902716 - Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfone group
10. 9884849 - Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfoximine group
11. 9877954 - 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
12. 9856242 - 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
13. 9790189 - Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine group
14. 9770445 - Sulfoximine substituted 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives and their use as CDK9 kinase inhibitors
15. 9730929 - Substituted aminoimidazopyridazines